HemOnc Today


The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents

Indoor tanning declines, but more melanoma prevention efforts urgently needed

Cover Story

Active surveillance redefines paradigm for prostate cancer management


The value proposition in oncology: ASCO and ESMO bite the bullet

Derek Raghavan, MD, PhD

FDA News

FDA grants priority review to Keytruda for first-line treatment of advanced melanoma

FDA grants orphan drug designation to varlitinib for cholangiocarcinoma

FDA approves Adcetris for high-risk patients with classical Hodgkin's lymphoma

FDA clears low-dose CT lung cancer screening option

FDA grants orphan drug designation to inecalcitol for AML

FDA reports prescribing, dispensing errors between Brintellix, Brilinta

In the Journals

Model predicts hearing loss after chemoradiotherapy for head and neck cancer

MRD positivity prognostic of poor outcomes even after intensive therapy for B-ALL

MRI-based screening effective for pancreatic cancer detection

High TIL levels predict positive outcomes in HER-2–positive breast cancer

Lower intensity treatment regimen displays efficacy in older patients with AML

Low-dose olprinone reduces risk for atrial fibrillation after lung cancer surgery

Hypofractionated radiation, temozolomide effective in elderly patients with glioblastoma

Nearly 15 million women have no access to GYN oncology care

Testosterone therapy not linked to VTE

Study data show increase in use of Mohs' micrographic surgery for skin cancer treatment

Society of Gynecologic Oncology outlines recommendations for ovarian cancer prevention

Workers exposed to low-dose radiation face increased leukemia mortality risk

Treatment-related cardiac dysfunction common in adult survivors of childhood cancer

Treatment delays, missed diagnostic testing common among patients with lung cancer

Society establishes criteria, research goals for oncology nurse navigators

Physicians working sick despite health risk to patients

Patient confidence in trial participation unaffected by knowledge of placebo assignment

No link between statin use, increased OS in colorectal cancer

Single dose of bivalent HPV vaccine as effective as three

Researchers successfully transport blood samples via drones

Radiotherapy has modest impact on quality of life when added to ADT

Colorectal cancer more survivable when detected by screening vs. diagnostic colonoscopy

CA-IX predicts poor survival in resectable hepatocellular carcinoma

Concomitant antidepressant, NSAID use may raise risk for intracranial hemorrhage

Donepezil displays some cognitive benefit for patients with irradiated brain tumors

Diagnostic model predicts impending death in patients with cancer

Black men in the UK twice as likely to receive prostate cancer diagnosis

AGS-003 plus sunitinib shows promise for advanced renal cell carcinoma

ADAMTS mutations may predict chemotherapy response in ovarian cancer

Annual low-dose CT screening limits unnecessary surgery in patients with nonsolid lung nodules

ATRX mutation possible biomarker for rare neuroendocrine tumors

ATA releases first guidelines for pediatric thyroid nodules, cancer

Graft-versus-host disease causes enteric bacterial BSI in children after HCT

Esophageal cancer rates in men increase by nearly 50% in 30 years

Genomic alterations predict chemotherapy response in muscle-invasive bladder cancer

Gene expression profiling, SLNB improved prediction of metastasis risk in patients with melanoma

Elevated C-reactive protein predicts poorer outcomes in melanoma

Doxorubicin can be omitted from postoperative Wilms’ tumor treatment

Fluorescent molecular imaging helps identify lung adenocarcinomas

Earlier palliative care consultation may reduce hospital cost, length of stay

Institution Notes

ASH presents bridge grants to 13 investigators

Vanderbilt appoints radiation oncology chair

MD Anderson appoints orthopedic oncology department chair

ASTRO members receive fellows designation

NYU Langone appoints neuro-oncology chief

Pharmacology Consult

Effective methods exist to prevent, treat therapy-related dermatologic adverse events

Jai N. Patel, PharmD